Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

NCT04452214

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +28 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Hospital of The University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details

Related conditions